Adding value to the global Endpoint Development & Outcomes Assessment practice

Adelphi Values is pleased to announce a senior-level addition to its global Endpoint Development and Outcomes Assessment (EDOA) practice. On September 3rd Cheryl Coon will join Adelphi Values as an Associate Director from RTI Health Solutions, where she was most recently Director of Psychometrics.

With over 10 years of experience in patient-reported outcome (PRO) instrument development and refinement using both quantitative and qualitative methodology, Cheryl will provide senior leadership to projects centering around clinical outcome assessments in clinical trials, regulatory submissions, and publications across a broad range of therapeutic areas. Her expertise is in psychometrics, and her passion is navigating the current regulatory landscape.  Cheryl holds a PhD and an MA in Quantitative Psychology and a dual BA in Psychology and French, all from the University of North Carolina at Chapel Hill.

“Cheryl brings a wealth of specialist COA consulting experience to support the evolving needs of our clients” commented Bruce Charlesworth, Managing Director UK and USA. “I am both excited and delighted to welcome her to our Boston based team and believe she will provide a very significant contribution to the continued success of our global offering in this expanding area.  She is most certainly a recognised expert in the field, and importantly for Adelphi Values an expert with an understanding of client challenges.”

Cheryl serves as the topic editor for the Pharamacoeconomics, Outcomes and Health Policy section of Clinical Therapeutics, and has recently co-authored an expert review – US FDA patient-reported outcome guidance: great expectations and unintended consequences Expert Rev. Pharmacoecon. Outcomes Res. 13(4), 441–446 (2013). Please follow this link for more information

If you would like further information about Adelphi Values or how our experts can help you overcome the challenges of developing and commercialising healthcare products and services, please contact us or visit

Related categories

Company news